Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Boothe Douglas
 2. Date of Event Requiring Statement (Month/Day/Year)
12/18/2013		 3. Issuer Name and Ticker or Trading Symbol
PERRIGO Co plc [PRGO]
(Last)
(First)
(Middle)
C/O PERRIGO COMPANY, 515 EASTERN AVENUE		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
EVP & GM Perrigo Pharma
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

ALLEGAN, MI 49010		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Boothe Douglas
C/O PERRIGO COMPANY
515 EASTERN AVENUE
ALLEGAN, MI 49010		       EVP & GM Perrigo Pharma  

Signatures

/s/ Penny Bursma, attorney-in-fact for Mr. Douglas Boothe 12/20/2013
**Signature of Reporting Person Date

Explanation of Responses:

No securities are beneficially owned

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
 
Remarks:
Reflects the beneficial ownership of the reporting person at the time of his appointment as Exec. V.P. & General Manager RX of Perrigo Company plc ("New Perrigo") and does not include the securities acquired by the reporting person upon the consummation of the merger of Perrigo Company with a wholly owned subsidiary of New Perrigo (the "Merger") on December 18, 2013. The Merger was consummated after and conditioned on New Perrigo' s acquisition of Elan Corporation plc by means of a "scheme of arrangement", an Irish statutory procedure under the Companies Act of 1963. The reporting person will file a Form 4 reflecting his acquisition of New Perrigo securities in connection with the consummation of the Merger.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.